Novartis Venture Fund Takes Aim at Japanese Bioventures (Japan)
This article was originally published in PharmAsia News
Executive Summary
The Novartis Venture Fund, established by Swiss pharmaceutical giant Novartis, has recently been looking to invest in a number of Japanese entities. According to fund representatives, it is looking to invest in drugmakers, medical equipment manufacturers, and diagnostic drug producers. Before making any decisions, a Novartis team will determine if a start-up company has the right combination of technology and prospective products that would fulfill a market need. Asides from companies, the fund is also looking to invest in Japanese universities and research institutes with the goal of aiding them to get into business. (Click here for more - May Require Paid Subscription